← Open Payments lookup

BRANDI GEBHARDT: Open Payments

NPI 1780336982 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,378 in 120 payments from 18 companies in 2025. Trend: 2023 $164 · 2024 $133 · 2025 $2,378

Food & beverage: $2,378
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.12$351
Corium, LLC11$312
Otsuka America Pharmaceutical, Inc.15$222
E.R. Squibb & Sons, L.L.C.8$220
Axsome Therapeutics, Inc.12$208
Vanda Pharmaceuticals Inc.11$185
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$181
ABBVIE INC.10$169
Supernus Pharmaceuticals, Inc.14$138
Lundbeck LLC5$112

Products named: INGREZZA, REXULTI, Azstarys, COBENFY, Auvelity, FANAPT, CAPLYTA, VRAYLAR.

Industry payments across TX — which companies pay providers there.